Pacira | PCRX - 流动负债

金融业

USD

USD 1.26B

现金及等价物

USD 158.55M

USD 54.62M

USD 547.97M

USD 120.59M

USD 372.19M

USD 3.19M

USD 38.71M

790

EPS每股收益

USD 0.06

股本和储备

USD 693.11M

USD 142.25M

债务利息支出

USD 3.89M

USD 8.53M

USD 372.19M

USD 1.06B

USD 1.64M

USD 193.68M

USD 3.19M

普通股股本

USD 41.12M

52.68

USD 9.52M

USD 196.87M

销售和管理费用

USD 91.87M

USD 152.86M

贸易债权人

USD 15.15M

应收帐款人

USD 124.07M

	流动负债	更改		日
Assertio Holdings	USD 166.78M		34.25M	2025-09
Astellas Pharma	JPY 1.32T		873M	2025-12
Bristol-Myers Squibb	USD 28.14B		608M	2025-09
Cara Therapeutics	USD 11.04M		362K	2025-09
Coherus Biosciences	USD 140.39M		231.91M	2025-12
Heron Therapeutics	USD 96.1M		6.39M	2025-12
Ironwood Pharmaceuticals	USD 242.5M		9.98M	2025-09
J&J	USD 54.13B		3.26B	2025-12
Ligand Pharmaceuticals	USD 37.45M		6.91M	2025-12
Nektar Therapeutics	USD 53.54M		12.8M	2025-12
Novo Nordisk	DKK 215.66B		18.7B	2025-12
Omeros	USD 85.5M		2.28M	2025-06
Pacira	USD 120.59M		13.51M	2025-12
Perrigo	USD 1.01B		132.4M	2025-12
Pfizer	USD 36.6B		1.13B	2025-09
Supernus Pharmaceuticals	USD 338.17M		7.54M	2025-12
Teva Pharmaceutical Industries	USD 13.46B		1.96B	2025-12
Xeris Pharmaceuticals	USD 109.57M		6.63M	2025-12
Xoma	USD 28.3M		6.81M	2025-09
Zoetis	USD 2.24B		428M	2025-12